Company / PP&E (Net)
Neogen PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$339.1M
FY2025
5-year range
$100.5M / $339.1M
FY2021-FY2025
Trend
+22.4%
vs FY2024
Sector context
#60 of 135
Health Care
What the data says
At $339M, Neogen's pp&e (net) ranks #60 of 135 in the Health Care sector. PP&E (Net) has increased for 9 consecutive years, from $55M in FY2016 to $339M in FY2025.
Based on SEC 10-K filings.
$339M in FY2025 with a 5-year CAGR of +33.9%.
Improved from $199M to $339M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +45.3%
- 5-Year CAGR
- +33.9%
- 10-Year CAGR
- -
Sector benchmark
#60 of 135 in Health CareTop 44% of 135This company $339.1M Sector average $1.4B
▼
-75.1% below sector average
Key checks
Key Insights
- Neogen's pp&e (net) has grown for 9 consecutive years.
- 5-year CAGR of +33.9%, indicating consistent growth.
- In FY2025, pp&e (net) increased 22.4% year-over-year.
- Ranks #60 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $339.1M | +22.4% |
| FY2024 | $277.1M | +39.4% |
| FY2023 | $198.7M | +79.7% |
| FY2022 | $110.6M | +10.1% |
| FY2021 | $100.5M | +27.7% |
| FY2020 | $78.7M | +5.1% |
| FY2019 | $74.8M | +2.4% |
| FY2018 | $73.1M | +18.3% |
| FY2017 | $61.7M | +12.9% |
| FY2016 | $54.7M | +23.0% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026